We showed previously that TGFβ promotes BIRC5 expression in ovarian cancer cells, and that knockout of BIRC5 or inhibition of BIRC5 with YM155 attenuated the TGFβ pathway [24]. Here, BIRC5 is linked to ovarian carcinoma.